United Therapeutics EVP Mahon Paul A buys and sells shares.
ByAinvest
Thursday, Jan 15, 2026 4:35 pm ET1min read
UTHR--
United Therapeutics Corporation (UTHR) has announced that EVP and General Counsel, Paul A. Mahon, has made several transactions on January 15, 2026. Mahon purchased 8,300 shares at a price of $146.03 per share, while selling a total of 9,263 shares at various prices ranging from $468.32 to $474.74 per share. The transactions included the sale of 1,439 shares at $468.32, 1,307 shares at $470.37, 407 shares at $472.28, 3,531 shares at $469.34, 1,576 shares at $471.44, and 40 shares at $474.74.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet